Genzyme available for ‘fair value’, says Termeer
September 2, 2010Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis
Genzyme’s chief executive Henri Termeer has said his company could be for sale to Sanofi-Aventis if it offers a ‘fair …
Pfizer acquires ‘protein misfolding’ specialist
September 2, 2010Research and Development FoldRx, Pfizer, cystic fibrosis
Pfizer has bolstered its presence in rare and orphan diseases with the acquisition of FoldRx, a US drug discovery firm …
Cephalon chairman takes leave of absence
September 2, 2010Research and Development, Sales and Marketing Cephalon, appointment, research and development, sales and marketing
Cephalon’s chairman and chief executive Frank Baldino Jr is taking a medical leave of absence with immediate effect. The company …
CME Spotlight: Reshaping the healthcare conversation
September 2, 2010Medical Communications CME Spotlight
In a recent conversation with the head of an international group of medical agencies, I was somewhat surprised to hear …
Digital Pharma: Augmented reality gateway for Bayer haemophilia site
September 1, 2010Medical Communications Digital Pharma blog, augmented reality, disease awareness campaigns, haemophilia
Bayer Healthcare has launched a new disease awareness campaign that uses augmented reality techniques to engage with its target audience. …
Lung cancer vaccine poised to begin phase IIb/III trials
September 1, 2010Research and Development NSCLC, TG4010, Transgene, cancer vaccine
French biotech firm Transgene has received positive scientific advice from the EMA for late stage trials of its new lung …
Eye treatment could be commercial breakthrough for ThromboGenics
September 1, 2010Research and Development ThromboGenics, eye care, microplasmin
Belgian biopharma company ThromboGenics could have a major product on its hands in the shape of new eye treatment. The …
EMA to assess GSK flu vaccine for narcolepsy link
September 1, 2010Research and Development, Sales and Marketing GlaxoSmithKline, Pandemrix, h1n1
The European Medicines Agency has launched a review of GlaxoSmithKline’s influenza vaccine Pandemrix. The European Commission asked the EMA to …
Pharma and the iPhone: there’s an app for that
September 1, 2010Medical Communications, Research and Development, Sales and Marketing ipad, iphone
The iPhone and its new, larger cousin the iPad, have captured the hearts of many technology lovers, and have ushered …
Kendle appoints Mark Roseman chief marketing officer
September 1, 2010Research and Development Kendle, appointment, research and development
Mark Roseman has joined clinical research organisation Kendle as senior vice president and chief marketing officer. He has more than …
Talking R&D: Strategic vs full service CRO
September 1, 2010Research and Development CRO, Talking Point, Talking R&D
CRF Health’s Greg Jewett and Medpace’s Alita Hassan debate the merits of a strategic or a full service contract research …
Roche coy on job cut reports
September 1, 2010Manufacturing and Production, Research and Development, Sales and Marketing Roche, job cuts
Roche is reportedly set to cut thousands of pharma jobs to reduce costs and boost profitability following a series of …
Paul Phull joins PharmaVentures
August 31, 2010Sales and Marketing PharmaVentures, appointment, sales and marketing
Oxford, UK-based PharmaVentures has appointed Paul Phull as a senior director to its corporate advisory business. He joins the company …
Swiss approval for Novartis’ Tasigna
August 31, 2010Sales and Marketing Novartis, Tasigna, Tekamlo
Novartis’ Tasigna has received its first European approval as a first-line treatment after Swiss authorities green-lighted the blood cancer drug …
Sanofi’s $18.5bn bid for Genzyme rejected
August 31, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis
Sanofi-Aventis has gone public with its $18.5 billion offer for Genzyme after the US biotech’s board unanimously rejected the bid …
Lonza buys Vivante to get bigger in biologics
August 31, 2010Manufacturing and Production Lonza, Vivante
Swiss contract manufacturer and fine chemicals firm Lonza has expanded its biologics production capacity with the purchase of US firm …
Swiss API manufacturer opens high-potency plant
August 31, 2010Manufacturing and Production API, Cerbios-Pharma
Cerbios-Pharma SA of Switzerland has officially opened its new high-potency active pharmaceutical ingredient manufacturing plant in Barbengo, a district in …
Hyaluron pulled up over particle contamination
August 31, 2010Manufacturing and Production Hyaluron, manufacturing compliance
US manufacturer Hyaluron has been sent a warning letter by the FDA after a routine inspection uncovered concerns with aseptic …
SOCMA welcomes US law easing raw material imports
August 27, 2010Manufacturing and Production Obama, SOCMA
US President Barack Obama has signed into law the Manufacturing Enhancement Act of 2010, designed to do away with import …
Chandler Chicco expands European services with Wright appointment
August 27, 2010Medical Communications Chandler Chicco, Cohn & Wolfe, Europe
Chandler Chicco has appointed Alison Wright to a newly created post to help increase the agency’s European and global services …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
